| Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study C Morgan, J Lappin, M Heslin, K Donoghue, B Lomas, U Reininghaus, ... Psychological medicine 44 (13), 2713-2726, 2014 | 140 | 2014 |
| Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study C Morgan, J Lappin, M Heslin, K Donoghue, B Lomas, U Reininghaus, ... Psychological medicine 44 (13), 2713-2726, 2014 | 140 | 2014 |
| Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort U Reininghaus, R Dutta, P Dazzan, GA Doody, P Fearon, J Lappin, ... Schizophrenia bulletin 41 (3), 664-673, 2015 | 139 | 2015 |
| Supported employment: randomised controlled trial LM Howard, M Heslin, M Leese, P McCrone, C Rice, M Jarrett, T Spokes, ... The British journal of psychiatry 196 (5), 404-411, 2010 | 107 | 2010 |
| Multiple Sclerosis in the UK P McCrone, M Heslin, M Knapp, P Bull, A Thompson Pharmacoeconomics 26 (10), 847-860, 2008 | 101 | 2008 |
| Ten-year outcomes of first-episode psychoses in the MRC ĘSOP-10 study CJ Revier, U Reininghaus, R Dutta, P Fearon, RM Murray, GA Doody, ... The Journal of nervous and mental disease 203 (5), 379, 2015 | 85 | 2015 |
| Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors A Demjaha, JM Lappin, D Stahl, MX Patel, JH MacCabe, OD Howes, ... Psychological Medicine 47 (11), 1981-1989, 2017 | 84 | 2017 |
| Diagnostic stability of ICD/DSM first episode psychosis diagnoses: meta-analysis P Fusar-Poli, M Cappucciati, G Rutigliano, M Heslin, D Stahl, Z Brittenden, ... Schizophrenia bulletin 42 (6), 1395-1406, 2016 | 82 | 2016 |
| Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders P Fusar-Poli, G Rutigliano, D Stahl, C Davies, A De Micheli, ... European Psychiatry 42, 49-54, 2017 | 75 | 2017 |
| Randomized controlled trial of supported employment in England: 2 year follow-up of the Supported Work and Needs (SWAN) study M Heslin, L Howard, M Leese, P McCrone, C Rice, M Jarrett, T Spokes, ... World Psychiatry 10 (2), 132, 2011 | 74 | 2011 |
| Diagnostic change 10 years after a first episode of psychosis M Heslin, B Lomas, JM Lappin, K Donoghue, U Reininghaus, A Onyejiaka, ... Psychological medicine 45 (13), 2757-2769, 2015 | 67 | 2015 |
| Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non … DL Scott, F Ibrahim, V Farewell, AG O’Keeffe, D Walker, C Kelly, F Birrell, ... bmj 350, h1046, 2015 | 51 | 2015 |
| Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes JM Lappin, C Morgan, S Chalavi, KD Morgan, A Reinders, P Fearon, ... Psychological medicine 44 (6), 1279-1291, 2014 | 38 | 2014 |
| Ethnicity and long-term course and outcome of psychotic disorders in a UK sample: the ĘsOP-10 study C Morgan, P Fearon, J Lappin, M Heslin, K Donoghue, B Lomas, ... The British Journal of Psychiatry 211 (2), 88-94, 2017 | 35 | 2017 |
| Scaling-up services for psychosis, depression and epilepsy in sub-Saharan Africa and South Asia: development and application of a mental health systems planning tool (OneHealth) D Chisholm, M Heslin, S Docrat, S Nanda, R Shidhaye, N Upadhaya, ... Epidemiology and Psychiatric Sciences 26 (3), 234-244, 2017 | 28 | 2017 |
| Comparison of effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies … D Ougrin, R Corrigall, J Poole, T Zundel, M Sarhane, V Slater, D Stahl, ... The Lancet Psychiatry 5 (6), 477-485, 2018 | 24 | 2018 |
| Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients M Heslin, JM Lappin, K Donoghue, B Lomas, U Reininghaus, A Onyejiaka, ... Schizophrenia research 176 (2-3), 417-422, 2016 | 21 | 2016 |
| The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for … N Huxley, L Crathorne, J Varley-Campbell, I Tikhonova, T Snowsill, ... Health Technology Assessment 21 (38), V-241, 2017 | 20 | 2017 |
| Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established … DL Scott, F Ibrahim, V Farewell, AG O'Keeffe, M Ma, D Walker, M Heslin, ... Health technology assessment (Winchester, England) 18 (66), i, 2014 | 19 | 2014 |
| Costs of the police service and mental healthcare pathways experienced by individuals with enduring mental health needs M Heslin, L Callaghan, B Barrett, S Lea, S Eick, J Morgan, M Bolt, ... The British Journal of Psychiatry 210 (2), 157-164, 2017 | 18 | 2017 |
Barbara BarrettKing's College LondonVerified email at kcl.ac.uk
Barbara BarrettKing's College LondonVerified email at kcl.ac.uk